loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 23325 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Noramco

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    OTHER PRODUCTS

    PharmaCompass

    PharmaCompass Sponsored Ads

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Noramco (1)

    filter

    01 NALTREXONE HYDROCHLORIDE DRUG SUBSTANCE (1)

    filter

    01 U.S.A (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    NORAMCO LLC

    Contact Supplier
    • FDA
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    NALTREXONE HYDROCHLORIDE DRUG SUBSTANCE

    PDF Supplier PDF
    URL Supplier Web Content
    23325
    Active
    2009-12-01
    Complete
    2014-01-14
    2013-12-20
    II
    Noramco

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 23325 of Noramco Llc

    Looking for Drug Master Files (DMF) for 23325 of Noramco Llc 1

    20

    Noramco Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    They are recognized for Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    One of their notable products is NALTREXONE HYDROCHLORIDE DRUG SUBSTANCE, with a corresponding US DMF Number 23325.

    Remarkably, this DMF maintains an Active status since its submission on December 01, 2009, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on December 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY